Tag: #Global Trends

Oxford Biomedica (OXB), a prominent CDMO specializing in cell and gene therapies, has finalized a licensing and option agreement with... Read more

Samsung Bioepis and Sandoz have entered into a global licensing, development, and commercialization agreement for up to five biosimilar candidates.... Read more

Pfizer has reached a significant milestone in its oncology expansion strategy with positive data from a clinical trial of its... Read more

A federal judge has issued a temporary injunction against several major policy changes directed by Health and Human Services (HHS)... Read more

Excalipoint Therapeutics, a Shanghai-based biotech newcomer, officially launched with $68.7 million in financing. The company focuses on developing multi-specific antibody... Read more

A recent report from U.S. Senator Maggie Hassan's office has sharply criticized GSK's management of its Flovent asthma inhaler. The... Read more

Geopolitical tensions in the Middle East are creating a ripple effect, directly threatening access to specialized medicines and medical supplies... Read more

U.S. health authorities have released a critical warning regarding numerous health supplements circulating on major online platforms that contain life-threatening... Read more

Eli Lilly has issued an open letter warning of a potentially dangerous chemical impurity found in compounded versions of Tirzepatide... Read more